Clinical Trials Directory

Trials / Completed

CompletedNCT06607354

Consuming Grass Finished Lamb Improves Blood Plasma ω-3 Fatty Acid Response Among Healthy Consumers.

The Effect of Consuming Grass Finished Lamb Meat on Omega-3 Blood Response Among Healthy Consumers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Queen's University, Belfast · Academic / Other
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Accepted

Summary

This study will investigate the impact of consuming grass-finished lamb meat on blood omega-3 PUFAs and cardiovascular risk factors compared to concentrate-finished lamb meat. Healthy volunteers will consume three portions of lamb meat/week from a grass-finished meat treatment or a concentrate-finished meat treatment for four weeks. Blood samples will be taken at weeks zero and four. The primary outcome is to assess difference in change in omega-3 PUFA concentration in plasma and platelets between treatment groups. The secondary outcome is to assess between groups differences in change in cardiovascular disease risk factors including blood pressure, BMI and lipids among healthy individuals.

Conditions

Interventions

TypeNameDescription
OTHERGrass fed lambThis study investigated the impact of consuming grass finished lamb on total blood plasma and blood plasma phospholipids (PL) FA and on cardiovascular risk factors, including heart rate, blood pressure (BP), HDL-cholesterol, LDL-cholesterol, and TAG cholesterol, in humans.

Timeline

Start date
2019-06-20
Primary completion
2019-12-13
Completion
2019-12-13
First posted
2024-09-23
Last updated
2024-09-24

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06607354. Inclusion in this directory is not an endorsement.